Newswise — A technology developed by scientists at Lawrence Berkeley National Laboratory (Berkeley Lab) shows great promise for diagnosing Alzheimer’s disease before symptoms arise, potentially changing the course of research and treatment for this condition, which affects millions of people worldwide and is estimated to be the sixth leading cause of death in the United States.
“This is a big deal,” said project leader Cynthia McMurray, following the publication of the team’s successful proof-of-principle study in the journal Scientific Reports. “Diagnosing Alzheimer’s disease at early stages is difficult and there is no way to predict who will get the disease, which means there is no successful pathway to develop therapeutics. However, this new technology uses accessible skin cells as surrogates to predict the disease status in the brain. We’re very excited for the…
